We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4.92B
AUM Growth
+$1.62B
Cap. Flow
+$1.41B
Cap. Flow %
28.67%
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$208M
2
AMZN icon
Amazon
AMZN
+$165M
3
AMD icon
Advanced Micro Devices
AMD
+$86.9M
4
XYZ
Block Inc
XYZ
+$33.2M
5
ROKU icon
Roku
ROKU
+$27M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$10.3M
2
MRNA icon
Moderna
MRNA
+$9.79M
3
JD icon
JD.com
JD
+$6.14M
4
AZN icon
AstraZeneca
AZN
+$5.27M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.32M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.5%
2 Technology 4.33%
3 Communication Services 2.49%
4 Healthcare 1.87%
5 Financials 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VVV icon
526
CALL
Valvoline
VVV
$5.06B
$839K 0.02%
+22,500
New +$785K
X
527
PUT
DELISTED
US Steel
X
$833K 0.02%
35,000
– –
YETI icon
528
Yeti Holdings
YETI
$3.87B
$828K 0.02%
+10,000
New +$918K
NVCR icon
529
NovoCure
NVCR
$1.77B
$826K 0.02%
+11,000
New +$1.1M
SNAP icon
530
CALL
Snap
SNAP
$7.96B
$823K 0.02%
17,500
– –
PACB icon
531
CALL
Pacific Biosciences
PACB
$435M
$818K 0.02%
+40,000
New +$965K
TWLO icon
532
PUT
Twilio
TWLO
$28.6B
$816K 0.02%
3,100
-300
-9% -$89.7K
MRTX
533
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$807K 0.02%
5,500
-8,500
-61% -$1.32M
GH icon
534
Guardant Health
GH
$19.1B
$800K 0.02%
+8,000
New +$827K
DKNG icon
535
CALL
DraftKings
DKNG
$12.2B
$797K 0.02%
+29,000
New +$1.14M
OTLY
536
CALL
Oatly Group
OTLY
$476M
$796K 0.02%
+5,000
New +$1.1M
ET icon
537
CALL
Energy Transfer Partners
ET
$69.5B
$782K 0.02%
95,000
-47,500
-33% -$432K
INVZ icon
538
Innoviz Technologies
INVZ
$84.1M
$782K 0.02%
+123,366
New +$707K
DIS icon
539
CALL
Walt Disney
DIS
$171B
$774K 0.02%
5,000
-18,000
-78% -$2.91M
AR icon
540
CALL
Antero Resources
AR
$10.9B
$770K 0.02%
44,000
+4,000
+10% +$75.8K
PBR icon
541
PUT
Petrobras
PBR
$120B
$769K 0.02%
70,000
– –
GM icon
542
PUT
General Motors
GM
$80.9B
$762K 0.02%
13,000
– –
CRIS icon
543
CALL
Curis
CRIS
$9.71M
$752K 0.02%
+395
New +$939K
BLU
544
CALL
DELISTED
BELLUS Health Inc.
BLU
$745K 0.02%
+92,600
New +$615K
CBRL icon
545
Cracker Barrel
CBRL
$1.26B
$740K 0.02%
+5,750
New +$767K
TASK icon
546
CALL
TaskUs
TASK
$594M
$734K 0.01%
+13,600
New +$742K
AZN icon
547
AstraZeneca
AZN
$269B
$728K 0.01%
6,250
-44,800
-88% -$5.27M
F icon
548
CALL
Ford
F
$60.9B
$727K 0.01%
+35,000
New +$644K
CALX icon
549
Calix
CALX
$2.24B
$720K 0.01%
9,000
+1,500
+20% +$97.9K
UBER icon
550
CALL
Uber
UBER
$145B
$713K 0.01%
17,000
– –
20 21
22
23 24

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q4 2021 Portfolio in Review

As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.

  • SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
  • SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
  • SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
  • SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
  • SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
  • SG3 Management opened 468 new positions and closed 410 in Q4 2021.
  • SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.